Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient

Breast CancerGastrointestinal CancerGynecologic Cancer

The diagnosis of a metastatic breast tumor from ovarian cancer by the succession of a p53 mutation: a case report

World J Surg Oncol.

Mori R, Futamura M, Morimitsu K, Saigo C, Miyazaki T, Yoshida K

doi: 10.1186/s12957-017-1185-5.

Gastrointestinal CancerSkin Cancer

Mismatch repair deficient metastatic colon cancer and urothelial cancer: a case report of sequential immune checkpoint therapy

Cancer Biol Ther.

Ghatalia P, Nagarathinam R, Cooper H, Geynisman DM, El-Deiry WS

doi: 10.1080/

Lung, Respiratory and Thoracic CancerFurther Publications

Response to Osimertinib in a Patient With Non-Small Cell Lung Cancer and Two Uncommon EGFR mutations

healthbook TIMES Oncology Hematology

Astaras C, Bettini A, Betticher D.C

doi: 10.36000/hbT.OH.2020.03.01

Lung, Respiratory and Thoracic Cancer

Detection of Driver and Resistance Mutations in Leptomeningeal Metastases of NSCLC by Next-Generation Sequencing of Cerebrospinal Fluid Circulating Tumor Cells

Clin Cancer Res.

Jiang BY, Li YS, Guo WB, Zhang XC, Chen ZH, Su J, Zhong WZ, Yang XN, Yang JJ, Shao Y, Huang B, Liu YH, Zhou Q, Tu HY, Chen HJ, Wang Z, Xu CR, Wang BC, Wu SY, Gao CY, Zhang X, Wu YL

doi: 10.1158/

Genitourinary Cancer

Genomic Testing for Advanced Prostate Cancer: Ready for Prime Time?

Alexander Meisela,b

doi: 10.36000/hbT.OH.2019.02.007

Head and Neck Cancer

Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma

Oncotarget.

Lechner A, Schlößer H, Rothschild SI, Thelen M, Reuter S, Zentis P, Shimabukuro-Vornhagen A, Theurich S, Wennhold K, Garcia-Marquez M, Tharun L, Quaas A, Schauss A, Isensee J, Hucho T, Huebbers C, Bergwelt-Baildon MV, Beutner D

doi: 10.18632/oncotarget.17901.

Breast Cancer

It is no longer the time to disregard thyroid metastases from breast cancer: a case report and review of the literature

BMC Cancer.

Pensabene M, Stanzione B, Cerillo I, Ciancia G, Cozzolino I, Ruocco R, Condello C, Di Lorenzo G, Giuliano M, Forestieri V, Arpino G, De Placido S, Lauria R

doi: 10.1186/s12885-018-4054-x.

COMMENTED

Gynecologic Cancer

Durable response to palbociclib and letrozole in ovarian cancer with CDKN2A loss

Cancer Biol Ther.

Frisone D, Charrier M, Clement S, Christinat Y, Thouvenin L, Homicsko K, Michielin O, Bodmer A, Chappuis PO, McKee TA, Tsantoulis P

doi: 10.1080/15384047.2019.1685291.

Gynecologic Cancer

Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analyses

Gynecol Oncol.

Bogani G, Tagliabue E, Ditto A, Signorelli M, Martinelli F, Casarin J, Chiappa V, Dondi G, Leone Roberti Maggiore U, Scaffa C, Borghi C, Montanelli L, Lorusso D, Raspagliesi F

doi: 10.1016/j.ygyno.2017.07.139.

Related content